(Reuters) -MIAX-parent Miami International Holdings on Friday reported a wider quarterly loss in its filing for a U.S.

One of biotech’s highest fliers, Sarepta Therapeutics, lost more than a third of its market value on Friday after executives said that one of its experimental gene-replacement therapies was linked to ...

CSN shares trade at a discount, but gradual deleveraging, stable margins, and strong dividends offer upside potential and ...

Fed governor Christopher Waller said he would take the central bank’s top job if offered. And a surge in trading activity boosted some brokerage profits last quarter. 🎧 Listen: Danny Lewis hosts our ...

Wall Street stocks closed mixed on Friday, with the S&P 500 and Nasdaq struggling to log significant gains as investors ...

Wall Street is drifting toward the finish of its third winning week in the last four. The S&P 500 rose 0.2% Friday after ...

WY Biotech is now obligated to pay a $7 million upfront license fee to HCW Biologics by Sept. 30, according to a filing with the Securities and Exchange Commission. HCW Biologics previously said it ...

Given high management fees and lackluster performance, we rate QQQI a sell and recommend investors stick with QQQ for tech ...

Miami International has grown to be the 14th largest global derivatives exchange operator as of June 30 since launching its first options exchange in 2012, the company said in a filing with the ...

Defense stocks, fast moving foreign banks, Tesla, Alphabet and others will be in focus for stock market investors in the coming week.

The Indian stock market declined for the second day on July 18, with the Sensex down 502 points to 81,757.73. Unimpressive ...

US wearable technology market was valued at USD 24 billion in 2024 and is expected to grow at a CAGR of 15.4% during the forecast period, 2025-2030.< ...